1. Home
  2. KNSA vs BY Comparison

KNSA vs BY Comparison

Compare KNSA & BY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • BY
  • Stock Information
  • Founded
  • KNSA 2015
  • BY 1914
  • Country
  • KNSA United Kingdom
  • BY United States
  • Employees
  • KNSA N/A
  • BY N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • BY Major Banks
  • Sector
  • KNSA Health Care
  • BY Finance
  • Exchange
  • KNSA Nasdaq
  • BY Nasdaq
  • Market Cap
  • KNSA 1.3B
  • BY 1.2B
  • IPO Year
  • KNSA 2018
  • BY 2017
  • Fundamental
  • Price
  • KNSA $18.73
  • BY $28.71
  • Analyst Decision
  • KNSA Strong Buy
  • BY Hold
  • Analyst Count
  • KNSA 5
  • BY 3
  • Target Price
  • KNSA $36.60
  • BY $32.00
  • AVG Volume (30 Days)
  • KNSA 469.7K
  • BY 115.3K
  • Earning Date
  • KNSA 02-26-2025
  • BY 01-23-2025
  • Dividend Yield
  • KNSA N/A
  • BY 1.26%
  • EPS Growth
  • KNSA N/A
  • BY 6.38
  • EPS
  • KNSA N/A
  • BY 2.76
  • Revenue
  • KNSA $384,098,000.00
  • BY $373,634,000.00
  • Revenue This Year
  • KNSA $60.05
  • BY N/A
  • Revenue Next Year
  • KNSA $36.74
  • BY $3.24
  • P/E Ratio
  • KNSA N/A
  • BY $10.36
  • Revenue Growth
  • KNSA 54.41
  • BY 9.77
  • 52 Week Low
  • KNSA $16.56
  • BY $19.70
  • 52 Week High
  • KNSA $28.15
  • BY $32.89
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 38.56
  • BY 48.73
  • Support Level
  • KNSA $18.27
  • BY $27.95
  • Resistance Level
  • KNSA $19.05
  • BY $28.83
  • Average True Range (ATR)
  • KNSA 0.61
  • BY 0.63
  • MACD
  • KNSA -0.05
  • BY 0.10
  • Stochastic Oscillator
  • KNSA 34.42
  • BY 76.19

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About BY Byline Bancorp Inc.

Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium-sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to our customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.

Share on Social Networks: